David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
VICI Properties
VICI
$29.2B
| $87.7M | 0.1% |
3,431,457
+1,918,547
| +127% | +$46.4M |
|
227
PUT
Cisco
CSCO
$438B
| $87.6M | 0.1% |
1,826,800
+1,001,900
| +121% | +$46.6M |
|
228
CALL
Chevron
CVX
$403B
| $87.3M | 0.1% |
724,300
+343,100
| +90% | +$40.4M |
|
229
Morgan Stanley
MS
$336B
| $87.1M | 0.1% |
1,703,830
-3,168,174
| -65% | -$150M |
|
230
Cardinal Health
CAH
$53.4B
| $87.1M | 0.1% |
1,721,496
-14,294
| -0.8% | -$738K |
|
231
F5
FFIV
$21.8B
| $86.3M | 0.1% |
617,956
+117,068
| +23% | +$16.5M |
|
232
Textron
TXT
$14.3B
| $85.6M | 0.1% |
1,919,127
+542,704
| +39% | +$25.1M |
|
233
Hartford Financial Services
HIG
$36.9B
| $85.4M | 0.1% |
1,405,408
-414,552
| -23% | -$24.9M |
|
234
Pediatrix Medical
MD
$2.16B
| $85.1M | 0.1% |
3,060,653
-522,728
| -15% | -$13.1M |
|
235
United Therapeutics
UTHR
$22B
| $84.5M | 0.1% |
959,171
+45,115
| +5% | +$3.97M |
|
236
State Street
STT
$51.4B
| $84.4M | 0.1% |
1,067,464
-2,340,903
| -69% | -$165M |
|
237
Atlassian
TEAM
$43.5B
| $84.4M | 0.1% |
701,201
-447,883
| -39% | -$54.5M |
|
|
PLAN
238
DELISTED
Anaplan, Inc.
PLAN
| $84.3M | 0.1% |
1,609,310
+921,148
| +134% | +$45.7M |
|
239
PUT
Western Digital
WDC
$166B
| $84.3M | 0.1% |
1,756,679
+223,190
| +15% | +$9.31M |
|
240
CALL
Procter & Gamble
PG
$336B
| $84.1M | 0.1% |
673,500
-73,300
| -10% | -$8.97M |
|
241
BlackLine
BL
$1.85B
| $84.1M | 0.1% |
1,630,611
+246,792
| +18% | +$12.3M |
|
242
Fortive
FTV
$18.1B
| $83.6M | 0.1% |
1,735,352
+207,870
| +14% | +$9.39M |
|
243
CALL
Goldman Sachs
GS
$303B
| $83.6M | 0.1% |
363,400
-12,900
| -3% | -$2.8M |
|
244
Cadence Design Systems
CDNS
$87.9B
| $82.8M | 0.09% |
1,193,739
+434,726
| +57% | +$29.2M |
|
|
245
CALL
Alibaba
BABA
$286B
| $82.7M | 0.09% |
390,000
+58,400
| +18% | +$11M |
|
246
Sempra
SRE
$54.2B
| $82.6M | 0.09% |
1,091,078
-217,582
| -17% | -$16M |
|
247
CALL
UnitedHealth
UNH
$350B
| $82.5M | 0.09% |
280,500
+121,700
| +77% | +$31.8M |
|
248
CALL
Salesforce
CRM
$171B
| $82.3M | 0.09% |
506,070
+83,700
| +20% | +$13.1M |
|
|
249
CALL
Morgan Stanley
MS
$336B
| $82M | 0.09% |
1,603,600
+115,700
| +8% | +$5.48M |
|
250
Vertex Pharmaceuticals
VRTX
$139B
| $81.9M | 0.09% |
373,973
-324,695
| -46% | -$65.7M |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.